A Study of Patients With Relapsing Remitting Multiple Sclerosis - NCT00882999-46202 (Clinical Trial 329181)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy329181.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Indianapolis |
|
State:
|
|
IN |
| Zip Code: |
|
46202 |
| Conditions: |
|
Relapsing-Remitting Multiple Sclerosis |
| Purpose: |
|
To look at the ability of LY2127399 to reduce magnetic resonance imaging (MRI) lesions at
12, 16, 20, and 24 weeks compared to placebo.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- 18 through 64 years of age diagnosed with relapsing-remitting multiple sclerosis
(RRMS), who can walk without aid or rest for at least 200 meters (approximately 1/10
of a mile).
- Women who can become pregnant must use birth control.
Exclusion Criteria:
- Have had a live vaccination within 12 weeks before randomization, or intend to have a
live vaccination during the course of the study.
- Have had had recent surgery or are scheduled to have surgery during the study.
- Are immunocompromised or have evidence of active infection (such as hepatitis,
tuberculosis or, human immunodeficiency virus [HIV]).
- Have been on certain drugs that are being studied for RRMS or have recently received
prescription drugs to treat RRMS.
- Have had a recent serious infection.
- Have serious or uncontrolled illnesses other than RRMS.
- Have clinically significant blood test values.
- Have multiple or severe drug allergies.
- Have contraindications for magnetic resonance imaging (MRI; "scanning") or
claustrophobia (fear of an enclosed space) that cannot be managed. |
|
|
|
| Study is available at: |
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Indianapolis, IN 46202
United States
Primary Contact:
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Phone: 1-317-615-4559 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|